VANCOUVER, BC, Dec. 29, 2020 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA" or the "Company") is pleased to announce that it has added two additional psychedelic compounds to its drug portfolio.
Exploring the companies and themes that make up this emerging and exciting new sector
2020 Was The Year of Psychedelics — Here's Why
While many 2020 memories will be gladly left behind, that's not necessarily the case for psychedelics.
The Year In Review For Psychedelic Drug Stocks: 2020
2020 was a very good year for the psychedelic drug industry. Psychedelic Stock Watch has compiled our own Report Card on industry performance.
UK’s first investment fund dedicated to psychedelic healthcare
In a first for the UK, an investment fund dedicated to psychedelic healthcare has been launched.
Numinus Completes First Extraction of its Psilocybe Mushrooms
VANCOUVER, BC , Dec. 17, 2020 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of solutions centred on the research, development, and delivery of safe, evidence-based, accessible psychedelic-assisted psychotherapies, has completed the first legal extraction of Psilocybe mushrooms in Canada by a public company for research and development purposes.
Numinus Completes First Extraction of its Psilocybe Mushrooms
Numinus announces the first legal extraction of psilocybe mushrooms in Canada by a public company.
How Psychedelic Drug Stocks Took Off in 2020
After some early turbulence in 2020, psychedelic drug stocks have taken off.
City Of Oakland Urges California To Decriminalize Psychedelics And Allow Healing Ceremonies
The Oakland City Council on Tuesday unanimously approved a resolution that calls on California state lawmakers to enact policies decriminalizing a wide range of psychedelicsand allowing local jurisdictions to permit healing ceremonies where people could use entheogenic substances.
Canadian Government Agency Removes Barrier for Psilocybin Therapy
PALM BEACH, Fla., Dec. 16, 2020 /PRNewswire/ -- Health Canada, in a recent "breakthrough Exemption" has quietly expanded its list of who can legally possess and consume psilocybin-containing mushrooms by granting 16 health-care professionals the same exemptions it gave more than a dozen patients with terminal and mental illnesses, according to TheraPsil, a Victoria non-profit that has been behind the struggle to treat a list of mental health issues, including debilitating depression, PTSD and even terminal cancer patients.
Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials
DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced therapeutic medicine for mainstream use, announced that it has partnered with ProPharma Group, the leading provider of regulatory and compliance services to the pharmaceutical, biotech, and medical device industries.
Push for Alternative Therapies Prods Researchers Towards Psilocybin
NEW YORK, Dec. 15, 2020 /PRNewswire/ -- The psychedelics market is currently navigating a similar legal situation to the one the cannabis market found itself in for many years.
MindMed Upsizes Previously Announced CAD $50m Bought Deal Public Offering
MindMed increases its latest bought-deal financing to CAD$80 million.